Stagezero Life Sciences Ltd (SZLSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,415 | -7,484 | -6,864 | -3,482 | -3,693 |
| Depreciation Amortization | 240 | 311 | 255 | 298 | 610 |
| Accounts receivable | 96 | -53 | -52 | N/A | 11 |
| Accounts payable and accrued liabilities | 3,400 | -395 | -144 | -468 | 277 |
| Other Working Capital | 3,709 | -460 | -81 | -377 | 343 |
| Other Operating Activity | 442 | -874 | 3,822 | -563 | -1,005 |
| Operating Cash Flow | $-3,529 | $-8,955 | $-3,064 | $-4,591 | $-3,457 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -102 | -72 | -33 | -7 |
| Net Acquisitions | N/A | 81 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $-21 | $-72 | $-33 | $-7 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 862 | 992 | 1,092 |
| Debt Issued | 598 | 16 | 29 | N/A | 1,542 |
| Debt Repayment | -40 | -145 | -120 | -110 | N/A |
| Common Stock Issued | 1,543 | 4,492 | 10,212 | 3,941 | 1,057 |
| Other Financing Activity | -267 | -260 | -1,320 | -233 | -163 |
| Financing Cash Flow | $1,833 | $4,103 | $9,663 | $4,589 | $3,529 |
| Exchange Rate Effect | -13 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 1,725 | 6,597 | 71 | 106 | 41 |
| End Cash Position | 16 | 1,725 | 6,597 | 71 | 106 |
| Net Cash Flow | $-1,709 | $-4,873 | $6,526 | $-35 | $65 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,529 | -8,955 | -3,064 | -4,591 | -3,457 |
| Capital Expenditure | N/A | -148 | -72 | -44 | -7 |
| Free Cash Flow | -3,529 | -9,103 | -3,137 | -4,635 | -3,464 |